Clinical trial
A Follow-Up Study of Patients Previously Treated in a Core Study With Pimecrolimus Tablets for Atopic Dermatitis
NCT00098150 is registered in ClinicalTrials.gov with Novartis as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Follow-Up Study of Patients Previously Treated in a Core Study With Pimecrolimus Tablets for Atopic Dermatitis
- Lead sponsor
- Novartis
- Phase
- Observational
- Overall status
- Completed
- Start date
- July 31, 2004
- Completion date
- Not reported
- Enrollment
- 66
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
atopic dermatitis